nitrates has been researched along with Dyslipidemias in 11 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to assess the associations of urinary thiocyanate, nitrate, and perchlorate concentrations with dyslipidemia, individually and in combination, which has not previously been studied." | 8.31 | Associations of thiocyanate, nitrate, and perchlorate exposure with dyslipidemia: a cross-sectional, population-based analysis. ( Cheang, I; Gao, R; Guo, Q; Li, X; Liao, S; Shi, M; Zhu, Q; Zhu, X, 2023) |
| "The aim of this study was to assess the associations of urinary thiocyanate, nitrate, and perchlorate concentrations with dyslipidemia, individually and in combination, which has not previously been studied." | 4.31 | Associations of thiocyanate, nitrate, and perchlorate exposure with dyslipidemia: a cross-sectional, population-based analysis. ( Cheang, I; Gao, R; Guo, Q; Li, X; Liao, S; Shi, M; Zhu, Q; Zhu, X, 2023) |
| "Dyslipidemia was showed by 52." | 1.48 | Relationship Between Erectile Dysfunction, Diabetes and Dyslipidemia in Hypertensive-Treated Men. ( Lahera, V; Lopez-Farre, AJ; Prieto, R; Puigvert, A; Rodriguez-Pardo, JM; Segura, A; Zamorano-Leon, JJ, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, M | 1 |
| Zhu, X | 1 |
| Cheang, I | 1 |
| Zhu, Q | 1 |
| Guo, Q | 1 |
| Liao, S | 1 |
| Gao, R | 1 |
| Li, X | 1 |
| Pan, X | 1 |
| Hong, F | 1 |
| Li, S | 1 |
| Wu, J | 1 |
| Xu, H | 1 |
| Yang, S | 1 |
| Chen, K | 1 |
| Baima, K | 1 |
| Nima, Q | 1 |
| Meng, Q | 1 |
| Xia, J | 1 |
| Xu, J | 1 |
| Guo, B | 1 |
| Lin, H | 1 |
| Xie, L | 1 |
| Zhang, J | 1 |
| Zhao, X | 1 |
| Zhang, Y | 1 |
| Zhao, J | 1 |
| Hu, Q | 1 |
| Mao, H | 1 |
| Wang, T | 1 |
| Koka, S | 1 |
| Xi, L | 1 |
| Kukreja, RC | 1 |
| Zamorano-Leon, JJ | 1 |
| Segura, A | 1 |
| Lahera, V | 2 |
| Rodriguez-Pardo, JM | 1 |
| Prieto, R | 1 |
| Puigvert, A | 1 |
| Lopez-Farre, AJ | 1 |
| Malagrino, PA | 1 |
| Sponton, CH | 1 |
| Esposti, RD | 1 |
| Franco-Penteado, CF | 1 |
| Fernandes, RA | 1 |
| Bezerra, MA | 1 |
| Albuquerque, DM | 1 |
| Rodovalho, CM | 1 |
| Bacci, M | 1 |
| Zanesco, A | 1 |
| Manivannan, J | 1 |
| Balamurugan, E | 1 |
| Silambarasan, T | 1 |
| Raja, B | 1 |
| Rueda-Clausen, CF | 1 |
| López-Jaramillo, P | 1 |
| Luengas, C | 1 |
| del Pilar Oubiña, M | 1 |
| Cachofeiro, V | 1 |
| Singh, K | 1 |
| Singh, T | 1 |
| Sharma, PL | 1 |
| Justo, ML | 1 |
| Rodriguez-Rodriguez, R | 1 |
| Claro, CM | 1 |
| Alvarez de Sotomayor, M | 1 |
| Parrado, J | 1 |
| Herrera, MD | 1 |
| Belaia, OL | 1 |
| Baĭder, LM | 1 |
| Kuropteva, ZV | 1 |
| Fomina, IG | 1 |
11 other studies available for nitrates and Dyslipidemias
| Article | Year |
|---|---|
Associations of thiocyanate, nitrate, and perchlorate exposure with dyslipidemia: a cross-sectional, population-based analysis.
Topics: Adult; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; | 2023 |
Long-term exposure to ambient PM
Topics: Adult; Air Pollutants; Air Pollution; Cholesterol, HDL; Cohort Studies; Dyslipidemias; East Asian Pe | 2023 |
Nitro substituent caused negative impact on occurrence and development of atherosclerotic plaque by PM
Topics: Air Pollutants; Animals; Apolipoproteins E; Atherosclerosis; Benzo(a)pyrene; Cholesterol; Dyslipidem | 2024 |
Chronic inhibition of phosphodiesterase 5 with tadalafil affords cardioprotection in a mouse model of metabolic syndrome: role of nitric oxide.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dyslipidemias; Heart; Insulin Resistance; Male; | 2020 |
Relationship Between Erectile Dysfunction, Diabetes and Dyslipidemia in Hypertensive-Treated Men.
Topics: Age Factors; Comorbidity; Diabetes Mellitus; Dyslipidemias; Erectile Dysfunction; Humans; Hypertensi | 2018 |
[Prevalence of dyslipidemia in middle-aged adults with NOS3 gene polymorphism and low cardiorespiratory fitness].
Topics: Cardiovascular System; Cholesterol; Dyslipidemias; Epidemiologic Methods; Female; Genotype; Glutamic | 2013 |
Diosgenin improves vascular function by increasing aortic eNOS expression, normalize dyslipidemia and ACE activity in chronic renal failure rats.
Topics: Animals; Antioxidants; Aorta; Diosgenin; Dyslipidemias; Endothelium, Vascular; Glutathione; Kidney; | 2013 |
Inflammation but not endothelial dysfunction is associated with the severity of coronary artery disease in dyslipidemic subjects.
Topics: Adult; Aged; C-Reactive Protein; Coronary Artery Disease; Dyslipidemias; Endothelium, Vascular; Huma | 2009 |
Beneficial effects of angiotensin (1-7) in diabetic rats with cardiomyopathy.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Glucose; Collagen; Diabetes Mellitus, Experimental; Di | 2011 |
Water-soluble rice bran enzymatic extract attenuates dyslipidemia, hypertension and insulin resistance in obese Zucker rats.
Topics: Adiponectin; Animals; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Diet; Dyslipidemias; | 2013 |
[Effects of mexidol on the antioxidative status of patients suffering from coronary heart disease with dislipidemia].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ch | 2005 |